TransMedics Group, Inc. (TMDX) stock
TMDXNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 14/3027% below fair value
$96.43+2.52 (+2.68%)
Close on Nov 18, 2026Market cap $3.34BP/E 25.0Yield 0.00%
TransMedics shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
TransMedics's shares outstanding was 41M at Jun 30, 2026. For fiscal 2025 it was 41M, up 15.1% from the year before. The highest annual figure on record is 41M in fiscal 2025.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 41M | +15.1% |
| FY2024 | Dec 31, 2024 | 35M | +8.3% |
| FY2023 | Dec 31, 2023 | 33M | +10.0% |
| FY2022 | Dec 31, 2022 | 30M | +7.0% |
| FY2021 | Dec 31, 2021 | 28M | +11.8% |
| FY2020 | Dec 31, 2020 | 25M | +73.9% |
| FY2019 | Dec 28, 2019 | 14M | +945.5% |
| FY2018 | Dec 29, 2018 | 1M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 41M | +0.4% |
| Q1 FY2026 | Mar 31, 2026 | 36M | -9.3% |
| Q4 FY2025 | Dec 31, 2025 | 41M | +16.2% |
| Q3 FY2025 | Sep 30, 2025 | 41M | +14.2% |
| Q2 FY2025 | Jun 30, 2025 | 41M | +14.9% |
| Q1 FY2025 | Mar 31, 2025 | 40M | +15.1% |
| Q4 FY2024 | Dec 31, 2024 | 35M | +7.9% |
| Q3 FY2024 | Sep 30, 2024 | 36M | +9.4% |
| Q2 FY2024 | Jun 30, 2024 | 35M | +8.4% |
| Q1 FY2024 | Mar 31, 2024 | 35M | +7.5% |
| Q4 FY2023 | Dec 31, 2023 | 33M | +1.9% |
| Q3 FY2023 | Sep 30, 2023 | 33M | +7.9% |
| Q2 FY2023 | Jun 30, 2023 | 33M | +16.3% |
| Q1 FY2023 | Mar 31, 2023 | 32M | +15.4% |
| Q4 FY2022 | Dec 31, 2022 | 32M | +15.4% |
| Q3 FY2022 | Sep 30, 2022 | 30M | +9.1% |
| Q2 FY2022 | Jun 30, 2022 | 28M | +1.3% |
| Q1 FY2022 | Mar 31, 2022 | 28M | +2.1% |
| Q4 FY2021 | Dec 31, 2021 | 28M | +2.3% |
| Q3 FY2021 | Sep 30, 2021 | 28M | +2.0% |
| Q2 FY2021 | Jun 30, 2021 | 28M | +18.4% |
| Q1 FY2021 | Mar 31, 2021 | 27M | +29.0% |
| Q4 FY2020 | Dec 31, 2020 | 27M | +28.3% |
| Q3 FY2020 | Sep 30, 2020 | 27M | +28.5% |
| Q2 FY2020 | Jun 30, 2020 | 23M | +77.6% |
| Q1 FY2020 | Mar 31, 2020 | 21M | +1396.2% |
| Q4 FY2019 | Dec 28, 2019 | 21M | +1418.8% |
| Q3 FY2019 | Sep 28, 2019 | 21M | +1444.4% |
| Q2 FY2019 | Jun 29, 2019 | 13M | +881.0% |
| Q1 FY2019 | Mar 30, 2019 | 1M | +4.4% |
| Q4 FY2018 | Dec 29, 2018 | 1M | – |
| Q3 FY2018 | Sep 29, 2018 | 1M | – |
| Q2 FY2018 | Jun 30, 2018 | 1M | – |
| Q1 FY2018 | Mar 31, 2018 | 1M | – |
See a number that looks wrong?